Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

AJ Kunz Coyne, A El Ghali, D Holger, N Rebold… - Infectious diseases and …, 2022 - Springer
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa
isolates are frequent causes of serious nosocomial infections that may compromise the …

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies

RF Langendonk, DR Neill, JL Fothergill - Frontiers in Cellular and …, 2021 - frontiersin.org
P. aeruginosa is classified as a priority one pathogen by the World Health Organisation, and
new drugs are urgently needed, due to the emergence of multidrug-resistant (MDR) strains …

Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence

MF Moradali, S Ghods, BHA Rehm - Frontiers in cellular and infection …, 2017 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic pathogen affecting immunocompromised
patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis (CF) …

Current choices of antibiotic treatment for Pseudomonas aeruginosa infections

D Ibrahim, JF Jabbour, SS Kanj - Current Opinion in Infectious …, 2020 - journals.lww.com
Factors that guide clinical decisions for empiric and directed P. aeruginosa therapy include
the epidemiology, the patient's risk factors, the site of infection, and the available treatment …

Antimicrobial drug resistance against Escherichia coli and its harmful effect on animal health

S Arbab, H Ullah, W Wang… - Veterinary Medicine and …, 2022 - Wiley Online Library
Multidrug resistance among pathogenic bacteria is imperilling the worth of antibiotic
infection, which has become an emerging problem, which previously transformed the …

Antibiotic resistant superbugs: assessment of the interrelationship of occurrence in clinical settings and environmental niches

AA Adegoke, AC Faleye, G Singh, TA Stenström - Molecules, 2016 - mdpi.com
The increasing threat to global health posed by antibiotic resistance remains of serious
concern. Human health remains at higher risk due to several reported therapeutic failures to …

Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa

N Mapara, M Sharma, V Shriram, R Bharadwaj… - Applied Microbiology …, 2015 - Springer
Pseudomonas aeruginosa is a leading opportunistic pathogen and its expanding drug
resistance is a growing menace to public health. Its ubiquitous nature and multiple …

Essential oils against bacterial isolates from cystic fibrosis patients by means of antimicrobial and unsupervised machine learning approaches

R Ragno, R Papa, A Patsilinakos, G Vrenna… - Scientific reports, 2020 - nature.com
Recurrent and chronic respiratory tract infections in cystic fibrosis (CF) patients result in
progressive lung damage and represent the primary cause of morbidity and mortality …

A review of recent advances in the treatment of adults with complicated urinary tract infection

E Rando, F Giovannenze, R Murri… - Expert Review of Clinical …, 2022 - Taylor & Francis
Introduction Complicated urinary tract infections (cUTIs) entail diverse clinical conditions that
could be managed differently and not necessarily with premature empiric therapy. Since …

Antimicrobial susceptibility monitoring of dermatological bacterial pathogens isolated from diseased dogs and cats across Europe (ComPath results)

C Ludwig, A De Jong, H Moyaert… - Journal of Applied …, 2016 - academic.oup.com
Abstract Aims The ComPath project is a pan‐European programme dedicated to the
monitoring of antimicrobial susceptibility of pathogens from diseased dogs and cats using …